Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction (Q34742822)

4 August 2017

title

Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction (English)

1 reference

4 August 2017

main subject

myocardial infarction

1 reference

1

John Z Ayanian

1 reference

4 August 2017

2

Bruce E Landon

1 reference

4 August 2017

5

Barbara J McNeil

1 reference

4 August 2017

3

Mary Beth Landrum

1 reference

4 August 2017

James R Grana

4

1 reference

4 August 2017

publication date

1 February 2002

1 reference

Journal of General Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

17

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

95-102

1 reference

Quality of ambulatory care after myocardial infarction among Medicare patients by type of insurance and region

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

USQA Health Profile Database as a tool for health plan quality improvement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Racial differences in the use of revascularization procedures after coronary angiography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Is knowing your cholesterol number harmful?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Management of primary hyperlipidemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study

7 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Variations in cholesterol management practices of U.S. physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495008

Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?

26 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Change in cholesterol awareness and action. Results from national physician and public surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

The National Cholesterol Education Program: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.10438.X

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11841524

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Change in public perspective on cholesterol and heart disease. Results from two national surveys

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11841524

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1525-1497.2002.10438.X

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference